Halozyme Therapeutics, Inc.

KORNITZER CAPITAL MANAGEMENT INC /KS HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

113,499

Value ($000)

7,638

Weight

0.2%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	7,638	0.2%	113,499	12/31/2025
2025 Q3	10/31/2025	8,324	0.2%	113,499	9/30/2025
2025 Q2	7/31/2025	6,596	0.1%	126,798	6/30/2025
2025 Q1	5/2/2025	13,122	0.3%	205,649	3/31/2025
2024 Q4	1/31/2025	10,193	0.2%	213,199	12/31/2024
2024 Q3	10/31/2024	25,292	0.5%	441,864	9/30/2024
2024 Q2	8/2/2024	27,370	0.5%	522,734	6/30/2024
2024 Q1	5/2/2024	19,739	0.4%	485,234	3/31/2024
2023 Q4	1/31/2024	17,546	0.3%	474,734	12/31/2023
2023 Q3	10/31/2023	17,248	0.4%	451,524	9/30/2023
2023 Q2	8/1/2023	15,394	0.3%	426,794	6/30/2023
2023 Q1	5/9/2023	16,200	0.3%	424,194	3/31/2023
2022 Q4	2/2/2023	17,374	0.4%	305,349	12/31/2022
2022 Q3	11/3/2022	17,711	0.4%	447,914	9/30/2022
2022 Q2	8/3/2022	19,713	0.4%	448,014	6/30/2022
2022 Q1	4/27/2022	21,803	0.4%	546,715	3/31/2022
2021 Q4	2/1/2022	21,983	0.3%	546,715	12/31/2021
2021 Q3	11/3/2021	18,913	0.3%	464,930	9/30/2021
2021 Q2	7/30/2021	21,112	0.3%	464,930	6/30/2021
2021 Q1	4/30/2021	17,164	0.3%	411,695	3/31/2021
2020 Q4	1/29/2021	17,583	0.3%	411,695	12/31/2020
2020 Q3	10/30/2020	12,149	0.2%	462,300	9/30/2020
2020 Q2	8/3/2020	12,527	0.3%	467,265	6/30/2020
2020 Q1	4/30/2020	8,469	0.2%	470,750	3/31/2020
2019 Q4	1/31/2020	4,732	0.1%	266,895	12/31/2019